Modeling The Economics Of Vaccine Manufacturing
Source: MilliporeSigma

There is a wide range of vaccine modalities that can be leveraged in vaccine production, each having its own set of advantages, disadvantages, and production costs. To determine which is best for a particular application, it is essential to understand, evaluate, and optimize costs to maximize production efficiency. This white paper describes the use of a custom-designed cost model to explore the economics of vaccine manufacturing when using different modalities.
access the White Paper!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
Subscribe to Cell & Gene
X
Subscribe to Cell & Gene
MilliporeSigma
This website uses cookies to ensure you get the best experience on our website. Learn more